![Christophe Bourdon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christophe Bourdon
Directeur/Membre du Conseil chez
SWEDISH ORPHAN BIOVITRUM AB
Profil
Christophe Bourdon is Chief Executive Officer at LEO Pharma A since 2022.
Mr. Bourdon is Director at Swedish Orphan Biovitrum AB since 2023.
Former roles include Chief Executive Officer at Strategic Partners A from 2021 to 2022, Senior Vice President & General Manager-US Oncology at Amgen, Inc. from 2020 to 2021, and Senior VP-Europe, Middle East, Africa & Canada at Alexion Pharmaceuticals, Inc. from 2015 to 2017.
Education includes an MBA from International Institute for Management Development and an undergraduate degree from Institut Supérieur de Gestion.
Postes actifs de Christophe Bourdon
| Sociétés | Poste | Début |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Directeur/Membre du Conseil | 01/01/2023 |
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Directeur Général | 01/01/2022 |
Anciens postes connus de Christophe Bourdon
| Sociétés | Poste | Fin |
|---|---|---|
| STRATEGIC PARTNERS A/S | Directeur Général | 01/04/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/03/2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2017 |
Formation de Christophe Bourdon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strategic Partners A/S
 Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Institut Supérieur de Gestion
 Institut Supérieur de Gestion Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
